Ketoprofene Lp Zentiva

Ketoprofen, the active ingredient in Ketoprofene Lp Zentiva, is a nonsteroidal anti-inflammatory drug presented as an oral dosage form for systemic use. It treats mild to moderate pain and inflammatory conditions such as rheumatoid arthritis, osteoarthritis, and musculoskeletal pain in adults.

GNH USA supplies Ketoprofene Lp Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoprofen is used to manage pain and inflammation associated with several musculoskeletal and rheumatic disorders.

Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility. Osteoarthritis: alleviates chronic joint pain and stiffness. Musculoskeletal pain: provides relief from acute injuries, sprains, and strains.

Ketoprofen may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia - Nausea or vomiting - Headache - Dizziness - Mild skin rash - Elevated blood pressure

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome - Hepatic injury or elevated liver enzymes - Renal impairment or acute kidney injury - Cardiovascular events such as myocardial infarction or stroke

Before initiating therapy, clinicians should consider several safety aspects.

Assess gastrointestinal risk: evaluate history of ulcers or bleeding before use. Monitor renal function: avoid in patients with severe kidney impairment. Check cardiovascular status: use cautiously in those with heart disease. Avoid concomitant use with other NSAIDs or anticoagulants unless necessary. Pregnancy and lactation: use only if benefits outweigh risks. Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Ketoprofen can interact with several drug classes, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function. - Lithium: NSAIDs can increase lithium levels. - Diuretics (e.g., thiazides): may impair renal clearance.